CORTICOBASAL DEGENERATION (CBD)
Clinical trials for CORTICOBASAL DEGENERATION (CBD) explained in plain language.
Never miss a new study
Get alerted when new CORTICOBASAL DEGENERATION (CBD) trials appear
Sign up with your email to follow new studies for CORTICOBASAL DEGENERATION (CBD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can tracking brain changes over time unlock the secrets of frontotemporal dementia?
Knowledge-focused Recruiting nowThis long-term study follows people with or at genetic risk for frontotemporal lobar degeneration (FTLD), a group of brain disorders that cause changes in behavior, language, and movement. Researchers will use brain scans, memory tests, and blood samples to measure how the diseas…
Matched conditions: CORTICOBASAL DEGENERATION (CBD)
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
PET scans reveal hidden brain inflammation in rare movement disorder
Knowledge-focused Recruiting nowThis study uses advanced PET scans and blood tests to examine brain inflammation and white matter damage in people with corticobasal syndrome, a rare movement and thinking disorder. Researchers will compare these brain changes across different subtypes of the condition and agains…
Matched conditions: CORTICOBASAL DEGENERATION (CBD)
Sponsor: Jennifer Whitwell • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
DNA hunt for rare brain disease genes begins
Knowledge-focused Recruiting nowThis study collects DNA from up to 1,000 adults with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple system atrophy (MSA), or related conditions, plus their family members. Researchers will sequence participants' whole genomes to find genetic variants …
Matched conditions: CORTICOBASAL DEGENERATION (CBD)
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC